November 17, 2020
NHMRC supports long-term household COVID-19 partnership study
A long-term COVID-19 study of household infections has received funding from the NHMRC.
All News
November 4, 2020
Professor Sharon Lewin named COVID-19 Communications Leader
The award celebrates life science leaders who are championing the sector and the Australian community through the pandemic.
November 3, 2020
APPRISED Issue 12 – October 2020
APPRISED – the newsletter of the APPRISE Centre of Research Excellence contains news about our response to infectious disease emergencies.
October 30, 2020
Professor Sharon Lewin: Conversation on COVID-19 with Dr Anthony Fauci
Professor Sharon Lewin reflects on her conversation with Dr Anthony Fauci, Director of the US National Institute of Allergy and Infectious Diseases.
October 28, 2020
Children may need to be vaccinated against COVID-19 too. Here’s what we need to consider
What are the issues with developing a safe and effective COVID-19 vaccine for children?
October 14, 2020
First Nations-led research projects awarded to address COVID-19 community needs
$2 million in grants have privileged First Nations voices and resulted in high-quality COVID-19 research projects
October 13, 2020
Sorry Melbourne. The chance of reaching an average five COVID-19 cases by mid-October is under 50%
How can Melbourne safely free up society and the economy without dashing all the results of the lockdown?
September 29, 2020
Expressions of interest – APPRISE Consultation Co-ordinator
APPRISE is seeking an experienced consultant to coordinate the development of future funding models and a five-year plan for APPRISE.
September 23, 2020
Professor Sharon Lewin presented with prestigious global virology award
Professor Sharon Lewin has been presented with the Global Virus Network’s (GVN) prestigious Robert C. Gallo Award for Scientific Excellence and Leadership in Medical Virology
September 23, 2020
Hotspot plan can make us one country again
Professors Sharon Lewin and John Kaldor explore how a unified approach to COVID-19 “hotspots” can re-open internal borders in Australia
